Detection of brain amyloid β deposition in patients with neuropsychological impairment after traumatic brain injury: PET evaluation using Pittsburgh Compound-B

References

• Kraus J, McArthur D. Epidemiology of brain injury. In: Cooper P, Golfinos J, editors. Head injury. 4th ed. New York: McGraw-Hill Publishers; 2000. pp 1–26
   Google Scholar
• Berger E, Leven F, Pirente N, Bouillon B, Neugebauer E. Ouality of life after traumatic brain injury: A systematic review of the literature. Restorative Neurology & Neuroscience 1999;14:93–102
   Web of Science ®Google Scholar
• Lyketsos CG, Lopez OL, Jones B, Fitzpatrick AL, Breitner J, DeKosky ST. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment. Journal of the American Medical Association 2002;288:1475–1483
   PubMed Web of Science ®Google Scholar
• Roberts GW, Gentleman SM, Lynch A, Murray L, Landon M, Graham DI. β Amyloid protein deposition in the brain after severe head injury: Implications for the pathogenesis of Alzheimer’s disease. Journal of Neurology, Neurosurgery & Psychiatry 1994;57:419–425
   PubMed Web of Science ®Google Scholar
• Ikonomovic MD, Uryu K, Abrahamson EE, Ciallella JR, Trojanowski JQ, Lee VM, Clark RS, Marion DW, Wisniewski SR, DeKosky ST. Alzheimer’s pathology in human temporal cortex surgically excised after severe brain injury. Experimental Neurology 2004;190:192–203
   PubMed Web of Science ®Google Scholar
• Nemetz PN, Leibson C, Naessens JM, Beard M, Kokmen E, Annegers JF, Kurland LT. Traumatic brain injury and time to onset of Alzheimer’s disease: A population-based study. American Journal of Epidemiology 1999;149:32–40
   PubMed Web of Science ®Google Scholar
• Guo Z, Cupples LA, Kurz A, Auerbach SH, Volicer L, Chui H, Green RC, Sadovnick AD, Duara R, DeCarli C, et al. Head injury and the risk of AD in the MIRAGE study. Neurology 2000;54:16–23
   Web of Science ®Google Scholar
• Lye TC, Shores EA. Traumatic brain injury as a risk factor for Alzheimer’s disease: A review. Neuropsychological Review 2000;10:115–129
   PubMed Web of Science ®Google Scholar
• Fleminger S, Oliver DL, Lovestone S, Rabe-Hesketh S, Giora A. Head injury as a risk factor for Alzheimer’s disease: The evidence 10 years on; a partial replication. Journal of Neurology, Neurosurgery & Psychiatry 2003;74:857–862
   PubMed Web of Science ®Google Scholar
• Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, Bergström M, Savitcheva I, Huang GF, Estrada S, et al. Imaging brain amyloid in Alzheimer’s disease with Pittsburgh compound-B. Annals of Neurology 2004;55:306–319
   PubMed Web of Science ®Google Scholar
• Ikonomovic MD, Klunk WE, Abrahamson EE, Mathis CA, Price JC, Tsopelas ND, Lopresti BJ, Ziolko S, Bi W, Paljug WR, et al. Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer’s disease. Brain 2008;131:1630–1645
   PubMed Web of Science ®Google Scholar
• Marshall LF, Marshall SB, Klauber MR, Van Berkum Clark M, Eisenberg H, Jane JA, Luerssen TG, Marmarou A, Foulkes MA. The diagnosis of head injury requires a classification based on computed axial tomography. Journal of Neurotrauma 1992;9(Suppl 1):S287--S292
   Google Scholar
• Yaqub M, Tolboom N, Boellaard R, van Berckel BNM, van Tilburg EW, Luurtsema G, Scheltens P, Lammertsma AA. Simplified parametric methods for [11C]PIB studies. Neuroimage 2008;42:76–86
   PubMed Web of Science ®Google Scholar
• Joachim CL, Morris JH, Selkoe DJ. Diffuse senile plaques occur commonly in the cerebellum in Alzheimer’s disease. American Journal of Pathology 1989;135:309–319
   PubMed Web of Science ®Google Scholar
• Yamaguchi H, Hirai S, Morimatsu M, Shoji M, Nakazato Y. Diffuse type of senile plaques in the cerebellum of Alzheimer-type dementia demonstrated by beta protein immunostain. Acta Neuropathologica 1989;77:314–319
   PubMed Web of Science ®Google Scholar
• Gentleman SM, Nash MJ, Sweeting CJ, Graham DI, Roberts GW. Beta-amyloid precursor protein (beta APP) as a marker for axonal injury after head injury. Neuroscience Letters 1993;160:139–144
   PubMed Web of Science ®Google Scholar
• Sherriff FE, Bridges LR, Sivaloganathan S. Early detection of axonal injury after human head trauma using immunocytochemistry for beta-amyloid precursor protein. Acta Neuropathologica 1994;87:55–62
   PubMed Web of Science ®Google Scholar
• Smith DH, Chen XH, Nonaka M, Trojanowski JQ, Lee VM, Saatman KE, Leoni MJ, Xu BN, Wolf JA, Meaney DF. Accumulation of amyloid beta and tau and the formation of neurofilament inclusions following diffuse brain injury in the pig. Journal of Neuropathology & Expermimental Neurology 1999;58:982–992
   PubMed Web of Science ®Google Scholar
• Smith DH, Chen XH, Iwata K, Graham DI. Amyloid β accumulation in axons after traumatic brain injury in humans. Journal of Neurosurgert 2003;98:107–1077
   Web of Science ®Google Scholar
• Chen XH, Siman R, Iwata A, Meaney DF, Trojanowski JQ, Smith DH. Long-term accumulation of amyloid-β, β-secretase, presenilin-1, and caspase-3 in damaged axons following brain trauma. American Journal of Pathology 2004;165:357–371
   PubMed Web of Science ®Google Scholar
• Chen XH, Johnson VE, Uryu K, Trojanowski JQ, Smith DH. A lack of amyloid β plaques despite persistent accumulation of amyloid β in axons of long-term survivors of traumatic brain injury. Brain Pathology 2009;19:214–223
   PubMed Web of Science ®Google Scholar
• Bacskai BJ, Frosch MP, Freeman SH, Raymond SB, Augustinack JC, Johnson KA, Irizarry MC, Klunk WE, Mathis CA, Dekosky ST, et al. Molecular imaging with Pittsburgh compound B confirmed at autopsy. Archives of Neurology 2007;64:431–434
   PubMed Web of Science ®Google Scholar
• Luukinen H, Viramo P, Koski K, Laippala P, Kivelä SL. Head injury and cognitive decline among older adults: A population-based study. Neurology 1999;52:557–562
   PubMed Web of Science ®Google Scholar
• Magnoni S, Brody DL. New perspectives on amyloid-β dynamics after acute brain injury: Moving between experimental approaches and studies in the human brain. Archives of Neurology 2010;67:1068–1073
   PubMedGoogle Scholar
• Mormino EC, Brandel MG, Madison CM, Rabinovici GD, Marks S, Baker SL, Jagust WJ. Not quite PIB-positive, not quite PIB-negative: Slight PIB elevations in elderly normal control subjects are biologically relevant. NeuroImage 2012;59:1152–1160
   PubMed Web of Science ®Google Scholar
• Kawai N, Maeda Y, Kudomi N, Yamamoto Y, Nishiyama Y, Tamiya T. Focal neuronal damage in patients with neuropsychological impairment after diffuse traumatic brain injury: Evaluation using 11C-flumazenil positron emission tomography with statistical image analysis. Journal of Neurotrauma 2010;27:2131–2138
   PubMed Web of Science ®Google Scholar
• Saunders AM, Strittmatter WJ, Schmechel D, George-Hyslop PH, Pericak- Vance MA, Joo SH, Rosi BL, Gusella JF, Crapper-MacLachlan DR, Alberts MJ. Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer’s disease. Neurology 1993;43:1467–1472
   PubMed Web of Science ®Google Scholar
• Kim J, Basak JM, Holtzman DM. The role of apolipoprotein E in Alzheimer’s disease. Neuron 2009;63:287–303
   PubMed Web of Science ®Google Scholar
• Teasdale GM, Nicoll JAR, Murray G, Fiddes M. Association of apolipoprotein E polymorphism with outcome after head injury. Lancet 1997;350:1069–1071
   PubMed Web of Science ®Google Scholar
• Nicoll JA, Roberts GW, Graham DI. Apolipoprotein E epsilon 4 allele is associated with deposition of amyloid beta-protein following head injury. Nature Medicine 1995;1:135–137
   PubMed Web of Science ®Google Scholar
• Kadir A, Marutle A, Gonzalez D, Schöll M, Almkvist O, Mousavi M, Mustafiz T, Darreh-Shori T, Nennesmo I, Nordberg A. Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer’s disease. Brain 2011;134:301–317
   PubMed Web of Science ®Google Scholar